IPO Insights

A NASDAQ path for CIS companies

Sukhrobjon (Rob) Ismoilov
Sukhrobjon (Rob) Ismoilov
Founder & Principal · Main Street Wealth

A working guide to preparing a CIS-based company for a NASDAQ or NYSE listing — governance, audit, disclosure, and the choice between a traditional IPO, RTO, or SPAC path.

Last updated
April 2026
15 min read
Share

The $15M threshold and why it matters

US public markets reward scale. For most Central Asian and CIS founders, $15M in annual USD revenue is the point at which a public-market pathway becomes credible — below that, private capital or regional listings almost always deliver a better outcome.

Governance and controls

US public-company standards touch every part of the business: board composition and independence, audit and compensation committees, disclosure controls, and internal control over financial reporting (SOX). The good news: most of this is buildable in 12–18 months with the right advisors.

PCAOB audit and financials

A transition to a PCAOB-registered audit firm is one of the biggest workstreams. Financial statements need to be re-audited (typically 2–3 years) under US GAAP or IFRS in a form acceptable to the SEC. Starting early is the single highest-leverage decision.

Traditional IPO vs. RTO vs. SPAC

  • Traditional IPO — deepest liquidity and best valuation, longest timeline, highest cost
  • Reverse Takeover (RTO) — 3–4 months to public, preserves ownership, smaller institutional bid
  • SPAC / de-SPAC — hybrid speed and structure, market-sensitive terms
  • Direct listing — rare fit for CIS issuers today

Full write-up in preparation

Executive summary and highlights below. Full report available on request under NDA.

Subscribe to our briefings

Quarterly briefings on Uzbekistan, Central Asia, and cross-border capital markets.